Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of a consolidation therapy
with bortezomib in patients with multiple myeloma aged 61 to 75.